Jason Park

Dr. Jason Park


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
KNKaterina Neumann
Katerina Neumann
NRNirmal Randhawa
Nirmal Randhawa
JPJason Park
Jason Park
DHDavid J. Hochman
David J. Hochman
Despite the increasing application of transanal endoscopic microsurgery (TEM) for rectal lesions, the cost of the equipment may play a role in a hospital’s hesitancy to invest in the platform. This study compares the cost of TEM to laparoscopic low anterior resection (LAR). Patients who underwent laparoscopic LAR (n = 24) for rectal neoplasm between 2006 and 2014 were case-matched based on sex, age, comorbidities, lesion size and location to patients who underwent TEM at a busy secondary care urban hospital. Procedure-related costs and costs associated with readmissions for complications and related subsequent surgeries in the first 3 years were calculated. There were 42 hospital admissions for 24 LAR patients, totalling 326 hospital days. For 24 TEM patients, there were 25 hospital admissions, totalling 56 hospital days. Subsequent operations for LAR patients included 2 washout and diverting ileostomies (8%), 2 adhesionolysis (8%), 4 ventral hernia repairs (16%) and 11 ileostomy reversals (46%). In the TEM group, there was one operation for recurrence (4%). The mean cost of LAR, including all related hospital costs in the subsequent 3 years, was CAD 14,851 (95% CI: CAD 10,124–19,579). The mean cost of TEM was CAD 2449 (95% CI: CAD 2133–2767; p < 0.0001), with a savings of CAD 12,402 per patient. TEM for rectal neoplasm is associated with significantly lower hospital costs, which far outweigh the costs of acquiring and maintaining the technology.

3 January 2022 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
GJGarrett G. R. J. Johnson
Garrett G. R. J. Johnson
JPJason Park
Jason Park
AVAshley Vergis
Ashley Vergis
LGLawrence Gillman
Lawrence Gillman
JRJustin D. Rivard
Justin D. Rivard

27 June 2022 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
JLJulie Lee
Julie Lee
HSHarminder Singh
Harminder Singh
KDKathleen Decker
Kathleen Decker
RHRamzi Helewa
Ramzi Helewa
MBMarylise Boutros
Marylise Boutros
JPJason Park
Jason Park
Dear Editor

8 February 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
Howard LimHoward Lim
Howard Lim
AAAswin G. Abraham
Aswin G. Abraham
Shahid AhmedShahid Ahmed
Shahid Ahmed
SAShahida Ahmed
Shahida Ahmed
CBCarl J. Brown
Carl J. Brown
AZAdnan Zaidi
Adnan Zaidi
An educational session related to the Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held virtually on 14 October 2020. The WCGCCC is an interactive multidisciplinary conference attended by health care professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba), who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists, radiologists, and allied health care professionals participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of total neoadjuvant therapy in rectal cancer.